Zhao Lu, Qiao Zhi-Dong, Jia Yue-Xin, Fu Jun-Xian, Li Tian-Xia, Jia Kai-Ru, Zhao Hong, Bao Jin-Ping, Yang Xiao-Fan, Pan Hao, Yang Guang-Lu
Department of Pediatrics, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, China.
Inner Mongolia Science and Technology Department, Inner Mongolia Autonomous Region Nervous System Disease Clinical Medical Research Center, Hohhot, China.
Mol Genet Genomic Med. 2025 Mar;13(3):e70083. doi: 10.1002/mgg3.70083.
To investigate the clinical and genetic characteristics of patients with ANK2(HGNC:493)-associated autism spectrum disorders (ASDs) and epilepsy (EP).
We identified a novel ANK2 variant in a patient with ASD and EP and summarized the clinical and genetic characteristics of ANK2 gene variants in this patient and those in previous reports.
A novel nonsense variant, ANK2 (NM_001148.6):c.3007C>T/p.R1003* in exon 27, was identified in one patient. We described the clinical features and molecular genetics of this patient and previously reported patients. This was discovered at a follow-up visit to the pediatric neurology department where genetic testing based on condition identified this rare genetic variant. He mainly presents with language delay, intellectual disability, limited learning, and communication skills, and later develops seizures, combined with common childhood neurological disorders such as hyperactivity, behavioral abnormalities, and even self-injury. The patient cohort included 16 patients with a complex array of neurological disabilities: ASD (9 patients); EP (10 patients); ASD with EP (4 patients); intellectual disability and developmental delay (5 patients); poor language communication (11 patients); language and learning impairment (11 patients); anxiety/agitation mood disorder (6 patients); attention-deficit/hyperactivity disorder (5 patients); cognitive, memory, and adaptability deficits (1 patient); tic disorder (1 patient); electrocardiogram and cardiac damage (1 patient); and abnormal electroencephalography (EEG) (9 patients).
For the first time, we identified a novel variant of the ANK2 gene in China, broadening the genetic spectrum of the ANK2 gene. ANK2 gene mutations can cause ASD, EP, ASD with EP, developmental delay and intellectual disability, poor language communication skills, language and learning disorders, anxiety/agitation mood disorder, and attention-deficit/hyperactivity disorder. Clinical ASD, EP, common EP should consider the ANK2 gene mutation.
探讨与ANK2(HGNC:493)相关的自闭症谱系障碍(ASD)和癫痫(EP)患者的临床及遗传特征。
我们在一名患有ASD和EP的患者中鉴定出一种新的ANK2变异,并总结了该患者及既往报道中ANK2基因变异的临床和遗传特征。
在一名患者中鉴定出一种新的无义变异,ANK2(NM_001148.6):第27外显子c.3007C>T/p.R1003*。我们描述了该患者以及既往报道患者的临床特征和分子遗传学情况。这是在小儿神经科的一次随访中发现的,基于病情进行的基因检测确定了这种罕见的基因变异。他主要表现为语言发育迟缓、智力残疾、学习和沟通能力有限,随后出现癫痫发作,还伴有常见的儿童神经障碍,如多动、行为异常,甚至自我伤害。患者队列包括16例患有一系列复杂神经残疾的患者:ASD(9例);EP(10例);ASD合并EP(4例);智力残疾和发育迟缓(5例);语言沟通不良(11例);语言和学习障碍(11例);焦虑/激动情绪障碍(6例);注意力缺陷多动障碍(5例);认知、记忆和适应能力缺陷(1例);抽动障碍(1例);心电图和心脏损害(1例);脑电图异常(9例)。
我们首次在中国鉴定出ANK2基因的一种新变异,拓宽了ANK2基因的遗传谱。ANK2基因突变可导致ASD、EP、ASD合并EP、发育迟缓、智力残疾、语言沟通能力差、语言和学习障碍、焦虑/激动情绪障碍以及注意力缺陷多动障碍。临床诊断为ASD、EP、常见癫痫时应考虑ANK2基因突变。